ThermoGenesis

Rancho Cordova, CA
Platform Provider
Cell Therapy
1 confirmed programs · 1 sponsors · Last scored 2026-04-02
57.8
Signal Score
○ FDA Inspections ✓ Clinical Trials (1) ○ SEC Filings ✓ Press (3) ○ EMA GMP ○ MHRA GMP

Quick Facts: ThermoGenesis

Signal Score
57.8/100 (as of 2026-04-02)
Quality Compliance
Assessment pending
Headquarters
Rancho Cordova, CA
Modalities
Cell Therapy
Active Programs
1 confirmed from ClinicalTrials.gov across 1 sponsors
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
Scored By
CDMO Signal — independent CDMO intelligence platform

Signal Score & Pillar Breakdown

Quality Compliance —
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations 60.0
1 active programs across 1 sponsors
Modalities: Cell Therapy
1 programs in advanced phases (Phase 2/3)
Source: ClinicalTrials.gov
1 active programs across 1 sponsors · Modalities: Cell Therapy · 1 programs in advanced phases (Phase 2/3)
Programs 1
Sponsors1
ModalitiesCell Therapy
1 active programs across 1 sponsors
Modalities: Cell Therapy
1 programs in advanced phases (Phase 2/3)
Source: ClinicalTrials.gov facility matching
NCT02538978 Critical Limb Ischemia Rapid Delivery by SurgWerks-CLI Kit... PHASE3 Unknown
Source: ClinicalTrials.gov · Retrieved Apr 05, 2026
Financial Stability 60.0
Private company
Financial assessment: 60.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity 53.0
1 manufacturing site: Rancho Cordova, CA
Modalities: Cell Therapy
Capacity assessment: 53.0/100
Sites: Rancho Cordova, CA
Source: SEC EDGAR, press monitoring, company profiles
1 manufacturing site
Recent Press3 articles
1 manufacturing site: Rancho Cordova, CA
Modalities: Cell Therapy
Capacity assessment: 53.0/100

Clinical Activity 1 studies

NCT02538978 Critical Limb Ischemia Rapid Delivery by SurgWerks-CLI Kit and VXP System PHASE3 Unknown
Source: ClinicalTrials.gov · Retrieved Apr 05, 2026

Recent News 3 articles

general 2026-04-01
ThermoGenesis Holdings Stock: Cell Therapy Leader with Growth Potential for North American Investors - AD HOC NEWS
ThermoGenesis Holdings Stock: Cell Therapy Leader with Growth Potential for North American Investors  AD HOC NEWS
Source →
general 2026-03-29
ThermoGenesis Holdings Stock: Pioneering Cell and Gene Therapy Tools Amid Biotech Sector Growth - AD HOC NEWS
ThermoGenesis Holdings Stock: Pioneering Cell and Gene Therapy Tools Amid Biotech Sector Growth  ad-hoc-news.de
Source →
general 2026-03-29
ThermoGenesis Holdings Stock: Pioneering Cell and Gene Therapy Tools Amid Biotech Sector Growth - ad-hoc-news.de
ThermoGenesis Holdings Stock: Pioneering Cell and Gene Therapy Tools Amid Biotech Sector Growth  AD HOC NEWS
Source →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Cell Therapy CDMOs →

Similar CDMOs

Charles River Laboratories
Newbury Park, CA · Memphis, TN · Keele, UK · Rockville, MD
Signal Score: 92.2
CAR-T, Cell Therapy, Gene Editing, Plasmid, AAV, Lentiviral
City of Hope (T Cell Manufacturing)
Duarte, CA
Signal Score: 84.9
CAR-T, Cell Therapy
Bayer (Cell Therapy Mfg)
Berkeley, CA
Signal Score: 83.8
Cell Therapy, Gene Editing
Eurofins CDMO
Planegg, DE · San Diego, CA
Signal Score: 81.6
Biologics, Cell Therapy
Cedars-Sinai Biomanufacturing
Los Angeles, CA
Signal Score: 78.9
Cell Therapy, Gene Editing